Oscar Health Q4 2022 Earnings Report
Key Takeaways
Oscar Health's Q4 2022 results demonstrated significant year-over-year improvement in core operating margins. The company's focus on cost management and administrative efficiency has positioned it well for future profitability.
Membership increased by 93% year-over-year, reaching 1,151,483 members as of December 31, 2022.
The InsuranceCo Combined Ratio improved by approximately 5 points year-over-year.
Oscar Health is introducing its outlook for 2023 with an anticipated InsuranceCo Combined Ratio at or less than 100%.
The company anticipates Direct and Assumed Policy Premiums of $6.4 billion to $6.6 billion for 2023.
Oscar Health
Oscar Health
Oscar Health Revenue by Segment
Forward Guidance
The Company is introducing its outlook for 2023 including anticipated Direct and Assumed Policy Premiums of $6.4 billion to $6.6 billion, an InsuranceCo Combined Ratio at or less than 100%, and a significantly improved Adjusted EBITDA loss of ($175) million to ($75) million.
Positive Outlook
- Direct and Assumed Policy Premiums of $6,400,000 to $6,600,000
- Medical Loss Ratio of 82% to 84%
- InsuranceCo Administrative Expense Ratio of 17% to 18%
- InsuranceCo Adjusted EBITDA of $20,000 to $120,000
- Adjusted Administrative Expense Ratio of 20.5% to 21.5%
Revenue & Expenses
Visualization of income flow from segment revenue to net income